Cargando…

Circulating miRNA-29b and Sclerostin Levels Correlate with Coronary Artery Calcification and Cardiovascular Events in Maintenance Hemodialysis Patients

OBJECTIVE: Coronary artery calcification (CAC) is a common complication in end-stage renal disease (ESRD) patients undergoing maintenance hemodialysis (MHD), and the extent of CAC is a predominant predictor of cardiovascular outcomes in MHD patients. In this study, we sought to uncover the relations...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Jiqing, Pan, Mingjiao, Xu, Mingzhi, Chen, Ruman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718313/ https://www.ncbi.nlm.nih.gov/pubmed/34976409 http://dx.doi.org/10.1155/2021/9208634

Ejemplares similares

Clinical significance of serum CDC42 in the prediction of uremic vascular calcification incidence and progression
por: Xu, Mingzhi, et al.
Publicado: (2023)

What is the relationship between sclerostin and cardiovascular events in hemodialysis patients?
por: Zhao, Yu, et al.
Publicado: (2020)

Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study
por: Brandenburg, Vincent M, et al.
Publicado: (2013)

Circulating levels of sclerostin are associated with cardiovascular mortality
por: Novo-Rodríguez, Cristina, et al.
Publicado: (2018)

Abdominal Aortic Calcification is Associated with Diastolic Dysfunction, Mortality, and Nonfatal Cardiovascular Events in Maintenance Hemodialysis Patients
por: Yoon, Hye Eun, et al.
Publicado: (2012)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Cardiovascular Events in Hemodialysis Patients: Challenging against Vascular Calcification
por: Kobayashi, Shuzo
Publicado: (2017)

Association of sclerostin with cardiovascular events and mortality in dialysis patients
por: Zou, Yun, et al.
Publicado: (2020)

Coronary artery calcifications predict long term cardiovascular events in non diabetic Caucasian hemodialysis patients
por: Noce, Annalisa, et al.
Publicado: (2015)

Coronary artery calcification, cardiovascular events, and death: a prospective cohort study of incident patients on hemodialysis
por: Wilkieson, Trevor J., et al.
Publicado: (2015)

The relationship between coronary artery calcification and bone metabolic markers in maintenance hemodialysis patients
por: Xiong, Lin, et al.
Publicado: (2023)

Association of aortic arch and aortic valve calcifications with cardiovascular risk in patients on maintenance hemodialysis
por: Liao, Min-Tser, et al.
Publicado: (2022)

Sclerostin Protects Against Vascular Calcification Development in Mice
por: De Maré, Annelies, et al.
Publicado: (2022)

Sclerostin and Cardiovascular Disease
por: Tobias, Jonathan H.
Publicado: (2023)

Associations of sclerostin with carotid artery atherosclerosis and all-cause mortality in Chinese patients undergoing maintenance hemodialysis
por: Chen, Aiqun, et al.
Publicado: (2018)

Impacts of Coronary Artery Calcification on Intradialytic Blood Pressure Patterns in Patients Receiving Maintenance Hemodialysis
por: Yeo, Seongyup, et al.
Publicado: (2020)

Serum sclerostin in vascular calcification in CKD: a meta-analysis
por: Lin, Yan, et al.
Publicado: (2023)

Analysis of miRNA Associated with Coronary Artery Calcification
por: Yang, Ning, et al.
Publicado: (2022)

Serum sclerostin is an independent predictor of mortality in hemodialysis patients
por: Gonçalves, Flávia Letícia Carvalho, et al.
Publicado: (2014)

Safety of Low-calcium Dialysate and its Effects on Coronary Artery Calcification in Patients Undergoing Maintenance Hemodialysis
por: Wen, Yang, et al.
Publicado: (2018)

Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis
por: ZHENG, Shubei, et al.
Publicado: (2018)

Association between serum cartilage oligomeric matrix protein and coronary artery calcification in maintenance hemodialysis patients
por: Ha, Lahati, et al.
Publicado: (2020)

Abdominal aortic calcification score can predict all-cause and cardiovascular mortality in maintenance hemodialysis patients
por: Bai, Jiuxu, et al.
Publicado: (2023)

Relation of Wnt Signaling Pathway Inhibitors (Sclerostin and Dickkopf-1) to Left Ventricular Mass Index in Maintenance Hemodialysis Patients
por: Bahie, Ahmed, et al.
Publicado: (2021)

Circulating microRNAs and vascular calcification in hemodialysis patients
por: Lee, Chien-Te, et al.
Publicado: (2019)

Sclerostin as Regulatory Molecule in Vascular Media Calcification and the Bone–Vascular Axis
por: De Maré, Annelies, et al.
Publicado: (2019)

Cardiovascular Calcifications Are Correlated with Inflammation in Hemodialysis Patients
por: Dragoș, Dorin, et al.
Publicado: (2023)

Serum Sclerostin, Body Composition, and Sarcopenia in Hemodialysis Patients with Diabetes
por: Medeiros, Maria Carolina, et al.
Publicado: (2020)

Circulating miRNA 122-5p Expression Predicts Mortality and Cardiovascular Events in Chronic Hemodialysis Patients: A Multicentric, Pilot, Prospective Study
por: Duni, Anila, et al.
Publicado: (2023)

Progression of coronary artery calcification in conventional hemodialysis, nocturnal hemodialysis, and kidney transplantation
por: Jansz, Thijs T., et al.
Publicado: (2020)

Circulating Sclerostin Levels Are Positively Related to Coronary Artery Disease Severity and Related Risk Factors
por: Frysz, Monika, et al.
Publicado: (2021)

Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021)

Dialysate Magnesium and Coronary Artery Calcification, Bone Mineral Density, and Cramping in Maintenance Hemodialysis: A Quasi-experimental Study
por: Srisuwarn, Praopilad, et al.
Publicado: (2021)

Relationship between the triglyceride–glucose index and coronary artery calcification in asymptomatic, non-diabetic patients undergoing maintenance hemodialysis
por: Ding, Hong, et al.
Publicado: (2023)

A small circulating miRNAs signature predicts mortality and adverse cardiovascular outcomes in chronic hemodialysis patients
por: Bolignano, Davide, et al.
Publicado: (2023)

Effect of adrenocorticotropic hormone infusion on circulating sclerostin levels
por: Zaheer, Sarah, et al.
Publicado: (2021)

Sarcopenia and echocardiographic parameters for prediction of cardiovascular events and mortality in patients undergoing maintenance hemodialysis
por: Zhang, Mengyan, et al.
Publicado: (2022)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Associations of Serum Dickkopf‐1 and Sclerostin With Cardiovascular Events: Results From the Prospective Bruneck Study
por: Klingenschmid, Gerhard, et al.
Publicado: (2020)

Fetuin-A, inflammation, and coronary artery calcification in hemodialysis patients
por: Turkmen, K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nqrg2lkv9143n69v3lal28j8rr